Gabelli & Co Investment Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-432,325	Closed	-$22.7M	–	401
2020 Q3	$22.7M	Buy	+432,325	New	+$17.9M	4.09%	2

Gabelli & Co Investment Advisers's MNTA Position: Q4 2020 in Review

Gabelli & Co Investment Advisers sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 432,325 shares — an estimated $22.7M sold.

Gabelli & Co Investment Advisers first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $22.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Gabelli & Co Investment Advisers reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 432,325 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $22.7M.
Gabelli & Co Investment Advisers first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Momenta Pharmaceuticals, Inc. position peaked at $22.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2020, filed 5 Feb 2021.